AstraZeneca PLC
1451.00
27-12月-24 08:24:20
15 分の遅延
株式
-3.00
-0.21%
本日の幅
1445.00 - 1459.50
ISIN
N/A
ソース
NASD.OMX SE
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 12 2023 02:39:09 提供 NASDAQ US Markets
-
AstraZeneca Launches Evinova Healthtech Business
20 11 2023 09:21:15 提供 NASDAQ US Markets
-
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use
17 11 2023 09:20:24 提供 NASDAQ Stocks
-
AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer
17 11 2023 03:04:07 提供 NASDAQ US Markets
-
Interesting AZN Put And Call Options For July 2024
16 11 2023 11:57:01 提供 NASDAQ Stocks
-
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
14 11 2023 03:55:47 提供 NASDAQ US Markets
-
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
10 11 2023 09:14:44 提供 NASDAQ Stocks
-
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
09 11 2023 18:26:41 提供 NASDAQ US Markets
-
AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows
09 11 2023 09:57:51 提供 Forbes - World
-
09 11 2023 06:19:20 提供 MarketWatch
-
09 11 2023 05:10:57 提供 MarketWatch
-
AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial
09 11 2023 03:55:26 提供 NASDAQ US Markets
-
AstraZeneca Q3 Pre-tax Profit Climbs; Lifts FY Outlook
09 11 2023 03:28:56 提供 NASDAQ US Markets
-
US FTC disputes listing for more than 100 patents in FDA Orange Book
07 11 2023 13:01:35 提供 NASDAQ US Markets
-
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
06 11 2023 14:44:08 提供 NASDAQ Stocks
-
AstraZeneca : Canada Approves Ultomiris For Adults With Neuromyelitis Optica Spectrum Disorder
01 11 2023 07:46:39 提供 NASDAQ US Markets
-
Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln
01 11 2023 05:05:04 提供 NASDAQ US Markets
-
Here’s Why You Could Be Giving Yourself—Or Someone Else—A Flu Shot Next Year
24 10 2023 08:18:46 提供 Forbes - World
-
AstraZeneca : FDA Accepts For Review SBLA For Self-administration Of Flumist Quadrivalent
24 10 2023 07:49:37 提供 NASDAQ US Markets
-
AstraZeneca : Enhertu Approved In EU For Advanced Non-small Cell Lung Cancer Treatment
23 10 2023 03:05:09 提供 NASDAQ US Markets